Cannabidiolic Acid (CBD-a) Research Dashboard
Loading research dashboard…
Page Quick Links
Loading filter…
Loading Primary Studies…
Loading Related Studies…
Overview - Cannabidiolic Acid (CBD-a)
Description of Cannabidiolic Acid (CBD-a)
The isolation and structure of cannabidiolic-acid (CBDA) was described by R. Mechoulam et al., in 1965.
The understanding of the pharmacodynamics and -kinetics of CBDA is more limited when compared to CBD.
Other Names:
Cannabidiolic AcidCannabidiolic acid, CBDA
IUPAC Name: 2,4-dihydroxy-3-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-6-pentylbenzoic acid
Molecular Formula: C22H30O4
Source–PubChem
Cannabidiolic Acid (CBD-a) Properties and Effects
Only Members can view Properties and Effects information. See DEMO page.
Cannabidiolic Acid (CBD-a) Receptor Binding
Only Members can view Receptor Binding information. See DEMO page.
Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You
should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a
medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.
